Korea-based medical software developer VUNO has earned CE mark certification for five of its artificial intelligence (AI) software products for use as diagnostic support tools.

The company’s AI software for bone age assessment, neurodegenerative disorder, chest X-ray, fundus screening, and pulmonary lung nodule detection and reporting are now cleared for use in Europe and in nonEuropean countries that recognize the CE mark.

VUNO said it is ready to ship the CE-marked software internationally.